# Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants

> **NCT06647407** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 750 (estimated)

## Conditions studied

- Meningococcal Immunization
- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** Pentavalent Meningococcal ABCYW vaccine
- **BIOLOGICAL:** MenACYW conjugate vaccine
- **BIOLOGICAL:** MenACYW conjugate vaccine
- **BIOLOGICAL:** Meningococcal group B vaccine
- **DRUG:** Paracetamol
- **BIOLOGICAL:** DTap-HepB-IPV-Hib vaccine
- **BIOLOGICAL:** DTap-HepB-IPV-Hib vaccine
- **BIOLOGICAL:** DTap-HepB-IPV-Hib vaccine
- **BIOLOGICAL:** Rotavirus vaccine
- **BIOLOGICAL:** Pneumococcal 13-valent conjugate vaccine

## Key facts

- **NCT ID:** NCT06647407
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-05
- **Primary completion:** 2027-05-17
- **Final completion:** 2027-05-17
- **Target enrollment:** 750 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06647407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06647407, "Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and Infants". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06647407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*